Suzuken Co., Ltd. (SZUKF)
USD 30.3
(0.0%)
USD 30.3
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 5.36 Billion USD | 10.58% |
| 2023 | 5.52 Billion USD | -6.99% |
| 2022 | 5.94 Billion USD | -5.69% |
| 2021 | 6.3 Billion USD | -2.76% |
| 2020 | 6.48 Billion USD | -8.9% |
| 2019 | 7.11 Billion USD | -1.32% |
| 2018 | 7.21 Billion USD | 12.77% |
| 2017 | 6.39 Billion USD | -8.37% |
| 2016 | 6.97 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 5.36 Billion USD | -9.05% |
| 2024 Q2 | 5.95 Billion USD | 15.22% |
| 2024 Q1 | 5.34 Billion USD | 5.1% |
| 2024 FY | 5.36 Billion USD | -2.94% |
| 2024 Q3 | 6.32 Billion USD | 0.41% |
| 2023 Q4 | 5.52 Billion USD | -18.65% |
| 2023 Q2 | 5.27 Billion USD | -3.87% |
| 2023 Q1 | 5.49 Billion USD | -7.62% |
| 2023 FY | 5.52 Billion USD | -6.99% |
| 2023 Q3 | 6.79 Billion USD | 28.74% |
| 2022 Q3 | 7.53 Billion USD | 13.22% |
| 2022 Q2 | 6.65 Billion USD | -1.93% |
| 2022 Q1 | 6.78 Billion USD | 7.68% |
| 2022 FY | 5.94 Billion USD | -5.69% |
| 2022 Q4 | 5.94 Billion USD | -21.11% |
| 2021 Q4 | 6.3 Billion USD | 0.0% |
| 2021 FY | 6.3 Billion USD | -2.76% |
| 2020 FY | 6.48 Billion USD | -8.9% |
| 2019 FY | 7.11 Billion USD | -1.32% |
| 2018 FY | 7.21 Billion USD | 12.77% |
| 2017 FY | 6.39 Billion USD | -8.37% |
| 2016 FY | 6.97 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Medicine Corporation | 21.33 Million USD | -25053.279% |
| DH Enchantment Inc. | 989.77 Thousand USD | -542099.907% |
| Exlites Holdings International, Inc. | 33.75 Thousand USD | -15900392.999% |
| Itonis, Inc. | 1.14 Million USD | -467742.575% |
| One Step Vending Corp. | 465.73 Thousand USD | -1152178.414% |
| MediPal Holdings Corporation | 7.02 Billion USD | 23.553% |
| PD-Rx Pharmaceuticals, Inc. | 1.69 Million USD | -316100.963% |
| Pharmagen, Inc. | 8868.81 USD | -60510559.175% |